Resources

Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 1 to 10 of 137 resources

  • Summary report: National Hepatitis C ODN Stakeholder Event 2020
    Eighteen months on from the start of NHS England’s hepatitis C elimination deal, HCV Action’s annual ODN event, co-hosted with the British Viral Hepatitis Group, explored how the UK has progressed towards elimination. It particularly focused on overcoming the challenges posed by the significant disruption of Covid-19 on healthcare services. This year’s event was held as a half-day webinar due to coronavirus-related restrictions and welcomed 129 participants from almost all ODNs and partner services.
    England 30 Oct 2020 Reports & Research, Tools & Templates, Strategy & Planning PDF
  • Summary report: Mitigating the impact of COVID-19 on HCV testing
    This is the written summary of a webinar held on 8th October on mitigating the impact of COVID-19 on HCV testing. The first part of the webinar consisted of three presentations: Overview of testing, before and after COVID-19 - Helen Hampton, Lead Clinical Nurse for Blood Borne Virus, We Are With You; Outreach testing during the COVID-19 lockdown - Julian Surey, Find and Treat Team; and Postal testing or self-testing - Tracey Kemp, National Hepatitis C Strategy Lead, Change Grow Live
    UK, England 30 Oct 2020 Case study, Tools & Templates, Strategy & Planning PDF
  • HCV Action ODN Stakeholder Event 2020: A national perspective on elimination
    These are the opening talks from this year's ODN Stakeholder Event from Mark Gillyon-Powell, Head of Programme for HCV Elimination, NHS England and Prof Graham Foster, National Clinical Lead for ODNs, NHS England. The talks gives a national overview on hepatitis C elimination efforts in England and how COVID-19 has impacted these. Professor Guruprasad Aithal, President of the British Association for the Study of the Liver (BASL) chaired the event. We will be publishing a written summary of the other presentations from this event soon.
    England 07 Oct 2020 Other, Strategy & Planning Video
  • Lessons learnt from HepCATT for ODNs and GP practices
    This summary notes some of the lessons learnt from the HepCATT (Hepatitis C Assessment Through to Treatment) Randomised Controlled Trial. HepCATT tested an Hepatitis C virus (HCV) case-finding intervention in primary care. The intervention involved: • Algorithm integrated into electronic patient records systems to identify high risk patients • Automatic mail-merge to create letters to invite high risk patients for testing • Pop-ups alerts in patient records to encourage opportunistic testing • Practice Staff HCV educational training
    UK, England Training, Tools & Templates, Strategy & Planning PDF
  • Good practice case study: Pop-up hepatitis C testing for people in supported accommodation during the COVID-19 outbreak
    During the COVID-19 pandemic, the ‘Everyone In’ policy meant that people who would otherwise be homeless were given accommodation in hotels. Surrey Operational Delivery Network, like many other ODNs, used this as an opportunity to engage with this cohort, offering testing and treatment for hepatitis C. This case study details how the team from Royal Surrey County Hospital and The Hepatitis C Trust were able to test people in these hotels and other forms of accommodation.
    UK, England, South East Case study, Strategy & Planning PDF
  • Summary report: Hepatitis C services during and beyond Covid-19 webinar - June 2020
    With the Covid-19 outbreak having caused significant disruption to healthcare services, including those for hepatitis C, HCV Action organised a webinar to discuss how services have been affected in different areas across the country and explore how hepatitis C services can most effectively be re-established as we emerge from the early phase of the outbreak. This report provides a summary of the remarks from each of the four speakers and the Q&A which followed.
    England 24 Jun 2020 Reports & Research, Tools & Templates, Strategy & Planning PDF
  • HCV Action webinar: Hepatitis C services during and beyond Covid-19
    With the Covid-19 outbreak having caused significant disruption to healthcare services, including those for hepatitis C, this webinar was organised to discuss how services have been affected in different areas across England and explore how hepatitis C services can most effectively be re-established as we emerge from the early phase of the outbreak. The webinar featured contributions from the following speakers: • Mark Gillyon-Powell - Head of Programme, HCV Elimination, NHS England & NHS Improvement • Dr Steve Ryder - Chair, HCV Action and Clinical Lead, Nottingham Hepatitis C ODN
    England 22 Jun 2020 Training, Strategy & Planning Video
  • Public Health England Hepatitis C in England 2020 Report
    Public Health England published its annual 'Hepatitis C in England' report on 30th May 2020. This reporting document monitors the England's progress towards its goal of eliminating the virus by 2030 and contains breakdowns of how testing and treatment are being delivered by service type, demographic and local area. This year's report notes significant increases in treatment availability over the last few years. It also suggests there have been increases in access to treatment for the people who inject drugs.
    England Reports & Research PDF
  • Laboratory reports of hepatitis C in England and Wales: October to December 2019
    This report from Public Health England breaks down the number of laboratory reports of hepatitis C tests carried out in England and Wales between October and December 2019 by age and gender. A breakdown is also provided by ODN in England.
    England, Wales 28 Apr 2020 Reports & Research PDF
  • Hepatitis C in London: 2019 report
    This report from Public Health England provides an update on the recent epidemiology of hepatitis C in London. Among the report's statistics are an estimate that 63% of people who inject drugs (PWID) in London had ever been infected with hepatitis C in 2018, with 41% of those ever infected having a current hepatitis C infection. It is estimated that 18% of PWID were unaware of their infection (lower than the 35% unaware in England as a whole). In 2017/18, 87% of eligible clients of drug treatment services received a hepatitis C test, a small increase from 86% in 2016/2017.
    England, Greater London 17 Feb 2020 Reports & Research PDF

Pages